Swiss National Bank’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-112,200
| Closed | -$845K | – | 2487 |
|
|
2024
Q1 | $845K | Hold |
112,200
| – | – | ﹤0.01% | 2298 |
|
|
2023
Q4 | $1.04M | Sell |
112,200
-11,400
| -9% | -$106K | ﹤0.01% | 2221 |
|
|
2023
Q3 | $1.25M | Buy |
123,600
+2,100
| +2% | +$21.3K | ﹤0.01% | 2113 |
|
|
2023
Q2 | $1.52M | Buy |
121,500
+15,200
| +14% | +$190K | ﹤0.01% | 2062 |
|
|
2023
Q1 | $1.24M | Sell |
106,300
-12,600
| -11% | -$147K | ﹤0.01% | 2122 |
|
|
2022
Q4 | $1.26M | Buy |
118,900
+3,300
| +3% | +$35.1K | ﹤0.01% | 2210 |
|
|
2022
Q3 | $1.12M | Buy |
115,600
+5,200
| +5% | +$50.4K | ﹤0.01% | 2272 |
|
|
2022
Q2 | $1.6M | Buy |
110,400
+5,800
| +6% | +$84.1K | ﹤0.01% | 2073 |
|
|
2022
Q1 | $2.73M | Buy |
104,600
+9,500
| +10% | +$248K | ﹤0.01% | 1850 |
|
|
2021
Q4 | $3.77M | Buy |
95,100
+11,400
| +14% | +$452K | ﹤0.01% | 1652 |
|
|
2021
Q3 | $4.19M | Buy |
83,700
+1,200
| +1% | +$60K | ﹤0.01% | 1590 |
|
|
2021
Q2 | $4.58M | Buy |
82,500
+43,600
| +112% | +$2.42M | ﹤0.01% | 1556 |
|
|
2021
Q1 | $1.82M | Buy |
38,900
+3,000
| +8% | +$140K | ﹤0.01% | 2060 |
|
|
2020
Q4 | $1.56M | Buy |
35,900
+1,400
| +4% | +$61K | ﹤0.01% | 2055 |
|
|
2020
Q3 | $1.26M | Buy |
34,500
+1,200
| +4% | +$43.9K | ﹤0.01% | 1958 |
|
|
2020
Q2 | $971K | Buy |
33,300
+15,800
| +90% | +$461K | ﹤0.01% | 2118 |
|
|
2020
Q1 | $458K | Hold |
17,500
| – | – | ﹤0.01% | 2219 |
|
|
2019
Q4 | $607K | Buy |
+17,500
| New | +$607K | ﹤0.01% | 2363 |
|